Purchase by Chen Bihua of 400000 shares of Biomea Fusion
BMEA Stock | USD 7.24 0.22 3.13% |
About 55% of Biomea Fusion's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Biomea Fusion suggests that some traders are interested. The current market sentiment, together with Biomea Fusion's historical and current headlines, can help investors time the market. In addition, many technical investors use Biomea Fusion stock news signals to limit their universe of possible portfolio assets.
Biomea |
Filed transaction by Biomea Fusion Inc director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Biomea Fusion's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Biomea Fusion's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Biomea Fusion Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Biomea Fusion can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biomea Fusion Fundamental Analysis
We analyze Biomea Fusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomea Fusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomea Fusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Biomea Fusion is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Biomea Fusion Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biomea Fusion stock to make a market-neutral strategy. Peer analysis of Biomea Fusion could also be used in its relative valuation, which is a method of valuing Biomea Fusion by comparing valuation metrics with similar companies.
Peers
Biomea Fusion Related Equities
CGEM | Cullinan Oncology | 2.75 | ||||
EWTX | Edgewise Therapeutics | 2.48 | ||||
IKNA | Ikena Oncology | 2.37 | ||||
HOWL | Werewolf Therapeutics | 1.52 | ||||
DSGN | Design Therapeutics | 0.50 |
Complementary Tools for Biomea Stock analysis
When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |